{"database": "lobbying", "table": "lobbying_activities", "rows": [[2526921, "ed4cc299-45e7-4e96-94bb-b007c26e628e", "Q3", "AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.", 288670, "AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC", 2020, "third_quarter", "HCR", "Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: \nHR 6514, Worker Health Coverage Protection Act\nHR 1425, Patient Protection and Affordable Care Enhancement Act \nIssues related to regulations for implementing section 1557 of the Affordable Care Act on anti-discrimination\nHR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act\nIssues related to the Senate HELP Committee initiative on preparing for future pandemics.\nRegulatory issues related to telehealth\nIssues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019;\nIssues relating to curbing health care costs;\nH.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act;\nAnti-cancer medication cost-sharing parity respecting H.R. 1409;  \nA national family caregiving strategy respecting S. 1719 and H.R. 1028;  \nAccess to medicines respecting FDA implementation of right to try law;\nIntroduction of the S. 3404 & H.R. 6102, Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020;\nH.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018;\nH. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; \nH.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials;\nAdditional issues related to reducing health disparities in cancer clinical trials;\nIssues related to capturing racial and ethnic data demographic data for communities disproportionately affected by coronavirus;\nH.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; \nH.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day\nH.R. 1730 and S. 741, the Cancer Drug Parity Act; \nCannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ;\nH.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act\nH.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019\nS. 2497, the Dependent Income Exclusion Act;\nIssues related to HHS regulation of prescription drug prices and costs;\nH.R. 4439, Creating Hope Reauthorization Act;\nH.R. 1730 and S. 741, the Cancer Drug Parity Act;\nH.R. 6556, the Gabriella Miller Kids First Research Act 2.0;\nH.R. 4439 & S. 4010, the Creating Hope Reauthorization Act;\nH.R.6666 & S. 4315, the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act, bill related to support needed data collection efforts to begin to contain coronavirus;\nIssues related to cancer survivorship and transitions of care from oncology treatment back to primary care;\nIssues related to improving data collection during the COVID-19 pandemic; and\nH.Res 1125, which expresses support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics in clinical trials for therapies, diagnostics, and vaccines for COVID -19. \nS 4557, COVID Enrollment Response Act (Sen. Baldwin)", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office", null, 815440, 0, 0, "2020-10-20T11:42:32.997000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2526921"], "units": {}, "query_ms": 18.947663018479943, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}